除非您已经将产品添加到购物车或收藏夹中，否则关闭操作不会保存您的定制内容。
单击“确认”以关闭MILLIPLEX® MAP工具，或单击“取消”以返回您的选择。
设计您的MILLIPLEX® MAP试剂盒并定价。
我们范围广泛的产品组合包括多元板面，允许您在板面中选择最符合您需求的分析物。在一个单独的选项卡上，您可以选择预混的细胞活素型或单试剂盒。
选择允许您探索整个路径或流程的固定试剂盒。或者通过选择单试剂MAPmates™，按照所提供的指南来设计您自己的试剂盒。
下列MAPmates™不应复合（plex）在一起：
-需要另一种 化验缓冲液的 MAPmates™。
-磷特异性和总MAPmate™对，例如总GSK3β和GSK3β（Ser 9）。
-PanTyr和现场特异性MAPmates™，例如磷-EGF受体和磷-STAT1（Tyr701）。
-单个靶多个磷-MAPmate™（Akt, STAT3）。
-GAPDH和β-微管蛋白不能与含有panTyr的试剂盒或MAPmates™复合（plex）在一起。
| 产品目录编号 | 订购说明 | 数量 / 包装 | 清单 |
| 选择品种 | . |
| 选择板面类型 | . |
| 选择试剂盒 | . |
| 选择样品类型 | 对于某些板面，样品类型将决定可以将哪些分析物复合（plex）在一起。 |
设计您自己的试剂盒，或者从我们预先混合的板面或单工板面中选择。
Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
| Catalogue Number | Ordering Description | Qty/Pack | List |
此产品已添加到您的购物车。
现在您可以定制另一个试剂盒了，您可选择预混试剂盒，结帐或关闭订购工具。
Webinar: Recent Developments in Oral Sustained Release Formulations
Modified release formulations offer numerous opportunities, including the possibility to improve the therapeutic efficacy of a drug. Out of the numerous approaches for modified release, each has its own benefits and drawbacks, as there is no one-size-fits-all solution for modified release formulations. Instead, there are various factors to be considered when choosing your approach.
On March 24, 2016, join us as we host a webinar “Recent Developments in Oral Sustained Release Formulations” in which we’ll discuss various solutions for sustained release formulations. By examining case studies and benchmarking data, we will look at well-established options as well as new functional excipients that may present an alternative.
Click here to register now for this webinar.
In This Same Issue
|
|
- New Lynx® CDR Connector Sizes Bring Increased Flexibility to Your Process
Now with a full range of sizes, the Lynx® CDR connector is available for use with multiple tube sizes... - Blood Plasma Website Gets Ultimate Makeover to Help Optimize Your Process
We’ve re-designed our website to function as your gateway to critical blood plasma fractionation resources... - Webinar Presents How to Reduce Risk of mAb Aggregation in Bioprocessing
Our webinar will explore how and why biological product aggregates form within a bioprocessing environment... - Winners of Emerging Biotech Grant Program Announced
We are excited to announce the winners of our 2016 Emerging Biotech Grant Program in Europe...